HEALTHY EXTRACTS INC. (HYEX): Entry into a Material Definitive Agreement
HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 hyex_ex10z1.htm SECURITIES PURCHASE AGREEMENT DATED JULY 17, 2026 Securities Purchase Agreement (Fire-Ubiquity) (00346656-5).DOCX SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 17, 2026, by and between Healthy Extrac
How this was made
The 30-second read
Why it matters
A new convertible note financing can create an overhang through expected dilution and potential selling pressure if the holder converts and liquidates shares. Traders will focus on conversion terms and any subsequent amendments or registration statements.
Market read
Convertible note financing is newly disclosed and can affect valuation via dilution expectations, even without immediate cash-flow guidance.
What to watch
Key trading drivers are missing from the excerpt: conversion price/ratio, maturity, interest rate, any beneficial ownership changes, and whether the buyer has registration rights or intends to convert/sell quickly.
Background
The 8-K reports entry into a material definitive agreement, specifically a securities purchase agreement for a convertible promissory note under Rule 506(b).
Ticker impact
Healthy Extracts Inc. entered a securities purchase agreement to issue a $258,750 convertible promissory note to LABRYS Fund II.
Near-term bias depends on conversion price/beneficial ownership details not included in the excerpt; expect potential dilution over time.
This is a primary 8-K disclosure of a capital raise instrument (convertible note). The excerpt provides principal and purchase price but not conversion mechanics, so directionality is uncertain.
Market effects
Microcap/small-cap financing via convertible notes can signal ongoing funding needs in the specialty extracts/biotech-adjacent space.
No clear regional spillover indicated by the filing excerpt.
Limited global relevance; this appears company-specific capital raising.
Counterpoint
If the conversion terms are favorable to the company (higher conversion price, limited discount, or capped dilution), the note could be less overhang than typical convertibles.
Key entities
- issuerHealthy Extracts Inc.
Nevada corporation that issued the convertible promissory note under the securities purchase agreement.
- buyerLABRYS Fund II, L.P.
Accredited investor purchasing the note for $225,000, with fee withholdings described in the agreement.
- placement_agentCarter, Terry, & Company, Inc.
Registered broker-dealer referenced as receiving a fee from the purchase price.